19:30-20:30 Jueves 6.10.2016 GUÍAS CLÍNICAS 2016 Y

GOA L
G U Í A S C L Í N I CA S 2 0 1 6 Y E V I D E N C I A
Optimizando el control del c-LDL
Jueves
6.10.2016
19:30-20:30
*En diferido las siguientes 24h
MODERADOR LOCAL:
Dr. D. Javier Rodríguez Collado. Cardiólogo del CAUSA
19.30
END OF THE CONTROVERSY
Chairs: Prof. Zamorano (Spain) Prof. Catapano (Italy)
19.35-19.45
Why are we Improving-IT every day?
Dr. Regina Dalmau (Spain)
19.45-19.55
CV Disease Prevention and Dyslipidemia
Guidelines: 2016 Update
Prof. Alberico Catapano (Italy)
19.55-20.05
The new era of intensive lipid-lowering therapy
Prof. Luis Masana (Spain)
20.05-20.15
A paradigm shift for patients and physicians.
What is the role of combination therapy?
Prof. Peter Toth (USA)
20.15-20.30
Q&A and closure
All & Prof. Jose Luis Zamorano (Spain) & Prof.
Alberico Catapano (Italy)
Merck Sharp & Dohme de España, S.A. C/ Josefa Valcárcel, 38 · 28027 Madrid.
www.msd.es Copyright © 2016 Merck Sharp & Dohme Corp., una subsidiaria de
Merck & Co., Inc., Kenilworth, NJ, USA. Todos los derechos reservados.
CARD-1191207-0000 (Creado: Julio 2016)